stockportfolio.pro
Stocks / JNJ vs UNH
JNJ vs UNH
Johnson & Johnson and UnitedHealth Group Incorporated side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Johnson & Johnson (JNJ) | UnitedHealth Group Incorporated (UNH) | |
|---|---|---|
| Market cap | $570.5B | $375.1B |
| Revenue (latest FY) | $94.19B | $447.57B |
| Net income (latest FY) | $26.80B | $12.06B |
| Revenue growth (5y CAGR) | 2.7% | 11.7% |
| Net margin | 28.5% | 2.7% |
| Return on equity | 32.9% | 12.0% |
| P/E ratio | 26.9 | 30.6 |
| Dividend yield | 2.3% | 2.3% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open JNJ — free Open UNH — freeFrequently asked questions
Which is bigger, JNJ or UNH?
Johnson & Johnson is larger by market capitalization — $570.5B versus $375.1B.
Which grows faster, JNJ or UNH?
Over the last five fiscal years, UnitedHealth Group Incorporated grew revenue faster — 11.7%/yr versus 2.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.